Joe Biden Taps Indian-American Vivek Murthy as Surgeon General: Report


PTI, Dec 4, 2020, 1:36 PM IST

US President-elect Joe Biden has tapped his key COVID-19 advisor Dr Vivek Murthy as the next Surgeon General, a role for which he was appointed during the Obama administration and had to leave abruptly during the current Trump administration, according to a media report. The 43-year-old Indian-American doctor is one of the three co-chairs of the Biden’s COVID-19 Advisory Board. Vivek H Murthy, a former US surgeon general, has been asked to reprise the role in an expanded version in the new administration, The Washington Post reported on Thursday, quoting an individual familiar with the decision. A formal announcement in this matter is expected soon.

The surgeon general serves a four-year term and is the top government official on public health issues. Jerome Adams is the incumbent Surgeon General. Murthy is expected to be part of a team of health-care officials charged with tackling the issue Biden has said would be his top priority upon taking office, according to people with knowledge of the matter, the report said.

He was appointed as the Surgeon General on December 15, 2014, after being approved by a 5143 Senate vote. He was relieved of his duties on April 21, 2017, by President Donald Trump. Politico on Thursday reported that Murthy will return to that role, but with a broader portfolio that will include acting as the top medical expert and public face of the effort. Another co-chair of the advisory board, Jeff Zients, is set to serve as the White House’s COVID-19 coordinator, the report said. Co-founder and president of Doctors for America, Dr Murthy was a hospitalist attending physician and instructor in medicine at Brigham and Women’s Hospital at Harvard Medical School, a position he has held since 2006.

In 2011, Murthy was appointed to serve as a Member of the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. Murthy has been the co-founder and Chairman of the Board of TrialNetworks, formerly known as Epernicus, since 2007. He co-founded VISIONS Worldwide in 1995, a non-profit organisation focused on HIV/AIDS education in India and the United States, where he served as president from 1995 to 2000 and Chairman of the Board from 2000 to 2003.

Murthy attended college at Harvard University and graduated in 1997 with a bachelor of arts in biochemical sciences. He earned an MD degree from Yale School of Medicine and an MBA from Yale School of Management.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Drugs worth Rs 6 crore seized in Bengaluru, five arrested

Siddaramaiah urges Nirmala Sitharaman to address NABARD’s loan cuts to farmers

Karnataka HC denies anticipatory bail to Prajwal Revanna in sexual harassment case

Delhi court stays defamation case against CM Atishi

Awards don’t create value for independent films in India: Manoj Bajpayee

Public Alert: Cyber fraudsters impersonating traffic police to demand fines

UP: 25 people booked for attacking civic officials for encroachment removal

Related Articles More

Bomb disposal squad tackles ‘security incident’ at UK’s Gatwick Airport

Baku climate talks: The ‘X’ factor that could determine future of Global South

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

PM Modi leaves for home after concluding three-nation visit

China announces new policy measures to protect its exports from Trump’s new tariff threat

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Air pollution: SC flags Delhi govt’s failure to implement GRAP-4 curbs on entry of trucks

Drugs worth Rs 6 crore seized in Bengaluru, five arrested

Siddaramaiah urges Nirmala Sitharaman to address NABARD’s loan cuts to farmers

Satwik-Chirag enter semifinals, Lakshya loses to Antonsen in China Masters

BJP stages protest against Congress govt in Karnataka over Waqf properties row

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.